
Learn the Intralesional curettage, cement augmentation and fixation with Synthes Philos plate for pathological humeral fracture surgical technique with step by step instructions on OrthOracle. Our e-learning platform contains high resolution images and a certified CME of the Intralesional curettage, cement augmentation and fixation with Synthes Philos plate for pathological humeral fracture surgical procedure.
The humerus is the second most appendicular common site of osseous metastatic disease after the femur. Metastatic bone disease causes pain, swelling, fracture and subsequent dysfunction. The management of such patients needs to be pragmatic, balancing multiple conflicting patient and technical factors including but not limited to the age, fitness and willingness of a patient to have surgery, estimated prognosis, extent of osseous or visceral metastatic disease, severity of symptoms and dysfunction, impending or pathological fracture, curative or palliative intent.
There are multiple surgical options although optimal use of non-operative interventions should not be overlooked by orthopaedic oncologists.
The present case is a fairly typical presentation of a patient with multiple osseous sites of metastatic prostate carcinoma with a pathological humeral fracture and an impending femoral fracture, who, after discussion with his oncology team, underwent stabilisation of his humerus first to enable the use of crutches after femoral reconstruction. The use of cement augmented plate stabilisation was selected in favour of resection and endoprosthetic replacement as surgery was palliative (i.e. a non-curative intervention to alleviate pain & increase function) and because the bone destruction was minimal. You can read about the technique for proximal humeral endoprosthetic replacement here: https://www.orthoracle.com/library/proximal-humeral-replacement-mutars-reverse-geometry-shoulder-implantcast/
Jonathan Stevenson FRCS (Tr&Orth)

INDICATIONS
Indications for surgery include pain, fracture or impending fracture, dysfunction and reduced quality of life.
Surgery ranges from internal fixation, with or without cement augmentation, to en-bloc excision and endoprosthetic replacement. Internal fixation may include plate stabilisation or intramedullary nail. An inappropriate choice of surgery risks mechanical failure, because the patient outlives the construct, and may hasten death because of the sequelae of surgical intervention. The decision to operate, as well as the choice of surgical procedure, depends on the estimated survival of the patient which is a calculation best made by a multidisciplinary orthopaedic oncology team.
The Synthes Philos plate is favoured in this case as it contoured to the anatomy of the proximal humerus, is available up to 286mm in length for diaphyseal tumours and has combination holes for locking screws for use in osteoporotic bone.
SYMPTOMS & EXAMINATION
This patient presented with a pathological fracture sustained pushing himself up out of bed, with a background of pain requiring opiates for six weeks. Such low-energy fractures are not typically associated with neuro-vascular dysfunction but these should be assessed and documented distal to the fracture site. Usually pain, swelling and some bruising and swelling around the elbow is all that is evident with a pathological humeral fracture.
IMAGING
Measured radiographs of the whole humerus and MRI of the whole humerus including joints above and below are required for local surgical planning. The degree of bone loss must be assessed pre-operatively: if it is too extensive then an endoprosthesis may be required.
Systemic staging of the patient is dependent upon histological diagnosis. In a case of metastatic bone disease CT chest-abdomen-pelvis to exclude visceral metastasis and whole-body bone scintigraphy to identify other skeletal metastases would be mandatory, although the bone scintigraphy may be performed afterwards to avoid any significant delay when a patient has already fractured.
ALTERNATIVE OPERATIVE TREATMENT
Surgical options range from plate stabilisation with cement augmentation to en-bloc resection and endoprosthetic reconstruction, which is determined by a) whether a curative resection is possible and b) the extent of osseous destruction in the humerus.
NON-OPERATIVE MANAGEMENT
In a patient without a fracture non-operative management in metastatic prostate carcinoma includes chemotherapy, immunotherapy, hormone therapy and radiotherapy. Consequently a discussion with the treating oncologist is advisable to ensure that all possible modalities of non-operative management have been considered before surgery.
Once a patient has suffered a fracture, the priority becomes pain relief and restoration of function in the non-curative setting.
CONTRAINDICATIONS
Contraindications include other co-morbidities precluding anaesthesia and therefore surgical intervention. Relative contraindications to endoprosthetic replacement would be estimated survival less than six months.

Patient is positioned supine under a general anaesthetic with a supplementary interscalene block plus a head-ring and an arm table positioned level with the right shoulder.
A U-Drape is secured beneath the axial and round to the anterior triangle of the neck.
Imaging intensification is used to check that visualisation of the proximal humerus is possible before the draping.
Chlorhexidine skin preparation and routine draping.
After draping an Ioban incisional drape is applied to the skin.
Diathermy and suction are made available.

HDU care.
VTE prophylaxis early mobilisation, flowtrons until mobile and TED stockings thigh length for six weeks, LMWH is not indicated in upper limb surgery but is indicated for endoprosthetic replacement around the hip for 28 days.
Removal of clips at two weeks.
24 hours of post-operative intravenous antibiotics (flucloxacillin).
Check x-rays AP lateral.
Post-operative radiotherapy after wound check at six weeks (single fraction of 8Gy of external beam radiotherapy each site).

Metastatic prostate carcinoma is the most common form of metastatic bone disease in males presenting to orthopaedic oncologists. There are many published methods for predicting survival in this group or patients. A UK study found biomarkers independently associated with poor survival were: low Hb, low Alb, relatively low PSA (< 30 mmol/l), and a raised ALP (https://online.boneandjoint.org.uk/doi/abs/10.1302/0301-620X.100B12.BJJ-2018-0697.R1).
Subspecialty training and patient and tumour characteristics influence the decision for operative management and the decision for a specific implant in metastatic fractures of the humerus (https://www.sciencedirect.com/science/article/pii/S1877056817303560). Orthopaedic oncologists are less likely to recommend medullary nail stabilisation of pathological humeral fractures and more likely to recommend cement augmented plate stabilisation or endoprosthetic reconstruction as these latter two options are believed to optimise pain relief and function and to reduce the incidence of mechanical failure and revision surgery (https://www.researchgate.net/profile/Teun_Teunis/publication/268336365_Outcome_of_operative_treatment_of_metastatic_fractures_of_the_humerus_a_systematic_review_of_twenty_three_clinical_studies/links/54c4dd170cf256ed5a95f3f7.pdf). Pathological fractures cannot be relied upon to heal after stabilisation and non-union is the most common indication for revision (https://pure.uva.nl/ws/files/29442597/Chapter_7.pdf).
Intralesional resection of the tumour, filling of the cavity with cement, and plate stabilisation of the pathological fracture gives immediate rigidity and allows an early return of function without the need for bony union and is associated with excellent clinical outcomes (https://pdfs.semanticscholar.org/93ae/bf1ec1d9962425532eda8651a60ffe9d360f.pdf). En-bloc excision and endoprosthetic reconstruction should be preserved for solitary metastases or where the humeral head is destroyed necessitating replacement.
Intralesional resection of the tumour, filling of the cavity with cement, and plate stabilisation of the pathological fracture gives immediate rigidity and allows an early return of function without the need for bony union and is associated with excellent clinical outcomes (https://pdfs.semanticscholar.org/93ae/bf1ec1d9962425532eda8651a60ffe9d360f.pdf). En-bloc excision and endoprosthetic reconstruction should be preserved for solitary metastases or where the humeral head is destroyed necessitating replacement.
Reference
- orthoracle.com














































